First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation

R Geyeregger; C Freimuller; J Stemberger; M Artwohl; V Witt; T Lion; G Fischer; A Lawitschka; J Ritter; M Hummel; W Holter; G Fritsch; S Matthes-Martin

doi:10.1097/CJI.0000000000000034

First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation

R Geyeregger, C Freimuller, J Stemberger, M Artwohl, V Witt, T Lion, G Fischer, A Lawitschka, J Ritter, M Hummel, W Holter, G Fritsch, S Matthes-Martin

Research output: Contribution to journal › Original Article › peer-review

41 Citations (Web of Science)

Original language	English
Pages (from-to)	245-249
Journal	JOURNAL OF IMMUNOTHERAPY
Volume	37
Issue number	4
DOIs	https://doi.org/10.1097/CJI.0000000000000034
Publication status	Published - 2014

Keywords

ADOPTIVE TRANSFER
VIRAL-INFECTIONS
CMV INFECTIONS
LYMPHOCYTES
THERAPY

Access to Document

10.1097/CJI.0000000000000034

Cite this

Geyeregger, R., Freimuller, C., Stemberger, J., Artwohl, M., Witt, V., Lion, T., Fischer, G., Lawitschka, A., Ritter, J., Hummel, M., Holter, W., Fritsch, G., & Matthes-Martin, S. (2014). First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation. JOURNAL OF IMMUNOTHERAPY, 37(4), 245-249. https://doi.org/10.1097/CJI.0000000000000034

@article{8a5b553a3c00425b8f46768c5b8803d9,

title = "First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation",

keywords = "ADOPTIVE TRANSFER, VIRAL-INFECTIONS, CMV INFECTIONS, LYMPHOCYTES, THERAPY",

author = "R Geyeregger and C Freimuller and J Stemberger and M Artwohl and V Witt and T Lion and G Fischer and A Lawitschka and J Ritter and M Hummel and W Holter and G Fritsch and S Matthes-Martin",

year = "2014",

doi = "10.1097/CJI.0000000000000034",

language = "English",

volume = "37",

pages = "245--249",

journal = "JOURNAL OF IMMUNOTHERAPY",

issn = "1524-9557",

publisher = "Lippincott Williams & Wilkins ",

number = "4",

}

Geyeregger, R, Freimuller, C, Stemberger, J, Artwohl, M, Witt, V, Lion, T, Fischer, G, Lawitschka, A, Ritter, J, Hummel, M, Holter, W, Fritsch, G & Matthes-Martin, S 2014, 'First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation', JOURNAL OF IMMUNOTHERAPY, vol. 37, no. 4, pp. 245-249. https://doi.org/10.1097/CJI.0000000000000034

First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation. / Geyeregger, R; Freimuller, C; Stemberger, J et al.
In: JOURNAL OF IMMUNOTHERAPY, Vol. 37, No. 4, 2014, p. 245-249.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation

AU - Geyeregger, R

AU - Freimuller, C

AU - Stemberger, J

AU - Artwohl, M

AU - Witt, V

AU - Lion, T

AU - Fischer, G

AU - Lawitschka, A

AU - Ritter, J

AU - Hummel, M

AU - Holter, W

AU - Fritsch, G

AU - Matthes-Martin, S

PY - 2014

Y1 - 2014

KW - ADOPTIVE TRANSFER

KW - VIRAL-INFECTIONS

KW - CMV INFECTIONS

KW - LYMPHOCYTES

KW - THERAPY

U2 - 10.1097/CJI.0000000000000034

DO - 10.1097/CJI.0000000000000034

M3 - Original Article

C2 - 24714358

SN - 1524-9557

VL - 37

SP - 245

EP - 249

JO - JOURNAL OF IMMUNOTHERAPY

JF - JOURNAL OF IMMUNOTHERAPY

IS - 4

ER -